MedTrace Logo

A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation

NCT01821079 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2013-05-21

No results posted yet for this study

Summary

The purpose of this study in healthy volunteers is to assess the relative bioavailability of PF-05175157 as powder-in-capsule and a tablet formulation and the effect of food on the pharmacokinetics of the tablet formulation.

Conditions

  • Healthy

Interventions

DRUG

PF-05175157

Single 200 mg dose of PF-05175157 administered as powder in capsule (2x100 mg)

DRUG

PF-05175157

Single 200 mg dose of PF-05175157 administered as tablet formulation (2x100 mg)

DRUG

PF-05175157

Single 200 mg dose of PF-05175157 administered as tablet formulation (2x100 mg)

DRUG

PF-05175157

Single 200 mg dose of PF-05175157 administered as tablet formulation (2x100 mg)

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01821079 on ClinicalTrials.gov